BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28291789)

  • 1. Applying a high-throughput fluorescence polarization assay for the discovery of chemical probes blocking La:RNA interactions in vitro and in cells.
    Sommer G; Fedarovich A; Kota V; Rodriguez R; Smith CD; Heise T
    PLoS One; 2017; 12(3):e0173246. PubMed ID: 28291789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
    Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
    ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1.
    Mahapatra L; Mao C; Andruska N; Zhang C; Shapiro DJ
    J Biomol Screen; 2014 Mar; 19(3):427-36. PubMed ID: 24108120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1536-well fluorescence polarization assay to screen for modulators of the MUSASHI family of RNA-binding proteins.
    Minuesa G; Antczak C; Shum D; Radu C; Bhinder B; Li Y; Djaballah H; Kharas MG
    Comb Chem High Throughput Screen; 2014; 17(7):596-609. PubMed ID: 24912481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay Optimization and Screening of RNA-Protein Interactions by AlphaScreen.
    Mills NL; Shelat AA; Guy RK
    J Biomol Screen; 2007 Oct; 12(7):946-55. PubMed ID: 17942787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation.
    Wang Z; Bhattacharya A; Ivanov DN
    PLoS One; 2015; 10(9):e0138780. PubMed ID: 26390015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput fluorescence polarization assay for chemical library screening against anti-apoptotic Bcl-2 family member Bfl-1.
    Zhai D; Godoi P; Sergienko E; Dahl R; Chan X; Brown B; Rascon J; Hurder A; Su Y; Chung TD; Jin C; Diaz P; Reed JC
    J Biomol Screen; 2012 Mar; 17(3):350-60. PubMed ID: 22156224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the RNA-binding protein La in cancer pathobiology.
    Sommer G; Heise T
    RNA Biol; 2021 Feb; 18(2):218-236. PubMed ID: 32687431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function.
    Grover P; Shi H; Baumgartner M; Camacho CJ; Smithgall TE
    PLoS One; 2015; 10(7):e0133590. PubMed ID: 26222440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-Modification of the La Protein Facilitates Binding to mRNA In Vitro and in Cells.
    Kota V; Sommer G; Durette C; Thibault P; van Niekerk EA; Twiss JL; Heise T
    PLoS One; 2016; 11(5):e0156365. PubMed ID: 27224031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of carboxyfluorescein-labeled 7-methylguanine nucleotides as probes for studying cap-binding proteins by fluorescence anisotropy.
    Wojtczak A; Kasprzyk R; Warmiński M; Ubych K; Kubacka D; Sikorski PJ; Jemielity J; Kowalska J
    Sci Rep; 2021 Apr; 11(1):7687. PubMed ID: 33833335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of RNA-protein interactions by a microplate-based fluorescence anisotropy assay.
    Mao C; Flavin KG; Wang S; Dodson R; Ross J; Shapiro DJ
    Anal Biochem; 2006 Mar; 350(2):222-32. PubMed ID: 16448619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Fluorescence Polarization in HTS Assays.
    Huang X; Aulabaugh A
    Methods Mol Biol; 2016; 1439():115-30. PubMed ID: 27316991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a High-Throughput, Compound-Multiplexed Fluorescence Polarization Assay to Identify ATG5-ATG16L1 Protein-Protein Interaction Inhibitors.
    Salkovski M; Pavlinov I; Gao Q; Aldrich LN
    SLAS Discov; 2021 Aug; 26(7):933-943. PubMed ID: 33783243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors.
    McWhirter C; Tonge M; Plant H; Hardern I; Nissink W; Durant ST
    J Biomol Screen; 2013 Jun; 18(5):567-75. PubMed ID: 23427045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay.
    Sun Y; Zang Z; Zhong L; Wu M; Su Q; Gao X; Zan W; Lin D; Zhao Y; Zhang Z
    PLoS One; 2013; 8(5):e63354. PubMed ID: 23691032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to target RNA binding proteins.
    Julio AR; Backus KM
    Curr Opin Chem Biol; 2021 Jun; 62():13-23. PubMed ID: 33535093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt-Dependent Modulation of the RNA Chaperone Activity of RNA-Binding Protein La.
    Sommer G; Sendlmeier C; Heise T
    Methods Mol Biol; 2020; 2106():121-136. PubMed ID: 31889254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer Displacement Screen for Flaviviral RNA Methyltransferase Inhibitors.
    Falk SP; Weisblum B
    J Biomol Screen; 2014 Sep; 19(8):1147-53. PubMed ID: 24793430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.